PUBLICATION

IRF3 attenuates hypoxia signaling by retaining HIF-α in the cytoplasm

Authors
Deng, H., Jia, S., Zhu, C., Hua, J., Wang, Z., Sun, X., Liu, W., Shi, L., Li, W., Gui, J.F., Liu, X., Xiao, W.
ID
ZDB-PUB-260112-3
Date
2026
Source
Cell Reports   45: 116815116815 (Journal)
Registered Authors
Xiao, Wuhan
Keywords
CP: Molecular biology, HIF-1α, HIF-2α, IRF3, cytoplasm, hypoxia
MeSH Terms
  • Animals
  • Basic Helix-Loop-Helix Proteins*/metabolism
  • Cell Hypoxia
  • Cytoplasm*/metabolism
  • HEK293 Cells
  • Humans
  • Hypoxia-Inducible Factor 1, alpha Subunit*/metabolism
  • Interferon Regulatory Factor-3*/genetics
  • Interferon Regulatory Factor-3*/metabolism
  • Mice
  • Signal Transduction*
  • Zebrafish
PubMed
41520336 Full text @ Cell Rep.
Abstract
Interferon regulatory factor 3 (IRF3) functions as a key transcription factor in the innate antiviral immune response, which depends on its nuclear localization. However, its function in the cytoplasm during non-infection states remains largely unknown. In this study, we found that resting cytoplasmic IRF3 interacts with hypoxia-inducible factor (HIF)-1α and HIF-2α, two master regulators of hypoxia signaling. This interaction retains HIF-α in the cytoplasm under hypoxic conditions, preventing it from exerting its transcription factor function and attenuating hypoxia signaling. Disruption of IRF3 in both mice and zebrafish resulted in increased expression of hypoxia response genes and enhanced tolerance to hypoxia. These findings suggest that, in the absence of viral infection, cytoplasmic IRF3 modulates hypoxia signaling by retaining HIF-α in the cytoplasm under hypoxic conditions.
Genes / Markers
Figures
Show all Figures
Expression
Phenotype
Mutations / Transgenics
Human Disease / Model
Sequence Targeting Reagents
Fish
Antibodies
Orthology
Engineered Foreign Genes
Mapping